Frontiers in Chemistry (Jan 2021)

Synthesis and Characterization of Macrocyclic Chiral Tröger’s Base Phenhomazine Candidates as Anticancer Agent

  • Alhussein A. Ibrahim,
  • Korany A. Ali,
  • Naglaa A. Abdel Hafez,
  • Mohamed A. Elsayed,
  • Khalid M. H. Mohamed,
  • Hanaa M. Hosni,
  • Abd El-Galil E. Amr,
  • Abd El-Galil E. Amr,
  • Elsayed A. Elsayed,
  • Elsayed A. Elsayed

DOI
https://doi.org/10.3389/fchem.2020.633065
Journal volume & issue
Vol. 8

Abstract

Read online

1,4,7,10-Tetraoxa[10](2,8)trögerophane 5 was synthesized from its corresponding precursors. Heating of 2 with p-nitrophenoxide afforded bis(p-nitrophenyl)ether 3, which was treated with hydrazine hydrate to give bis(p-aminophenyl)ether 4. Treatment of 4 with paraformaldehyde and triflouroacetic anhydride gave trögerophane 5. Reaction of 5 with trifluroacetic anhydride afforded phenhomazine derivative 6, which was treated with potassium carbonate to afford tetrahydrophenhomazine 7. Finally, reaction of 7 with phenacylchloride, bromoacetic acid, or ethyl bromoacetate in the presence of triethyl amine under reflux, afforded the corresponding macrocyclic compounds 8, 9 and 10, respectively. The synthesized trögerophane,precursors and its newly synthesized phenhomazines derivatives were screened for anticancer activity. Results revealed that 1,4,7,10-tetraoxa[10](2,8)trögerophane had a promising selectivity towards colon cancer cell line with an IC50 of 92.7 µg/ml.

Keywords